GO ID | Tissue | Disease Stage | Description | Gene Ratio | Bg Ratio | pvalue | p.adjust | Count |
GO:0071383 | Colorectum | AD | cellular response to steroid hormone stimulus | 73/3918 | 204/18723 | 6.31e-07 | 2.24e-05 | 73 |
GO:0030522 | Colorectum | AD | intracellular receptor signaling pathway | 87/3918 | 265/18723 | 3.69e-06 | 1.03e-04 | 87 |
GO:0043401 | Colorectum | AD | steroid hormone mediated signaling pathway | 51/3918 | 136/18723 | 6.52e-06 | 1.63e-04 | 51 |
GO:0048545 | Colorectum | AD | response to steroid hormone | 104/3918 | 339/18723 | 1.33e-05 | 2.90e-04 | 104 |
GO:0009755 | Colorectum | AD | hormone-mediated signaling pathway | 64/3918 | 190/18723 | 2.78e-05 | 5.24e-04 | 64 |
GO:0120162 | Colorectum | AD | positive regulation of cold-induced thermogenesis | 32/3918 | 97/18723 | 3.74e-03 | 2.63e-02 | 32 |
GO:0106106 | Colorectum | AD | cold-induced thermogenesis | 43/3918 | 144/18723 | 7.05e-03 | 4.31e-02 | 43 |
GO:0120161 | Colorectum | AD | regulation of cold-induced thermogenesis | 43/3918 | 144/18723 | 7.05e-03 | 4.31e-02 | 43 |
GO:1990845 | Colorectum | AD | adaptive thermogenesis | 46/3918 | 157/18723 | 7.97e-03 | 4.73e-02 | 46 |
GO:00713831 | Colorectum | SER | cellular response to steroid hormone stimulus | 55/2897 | 204/18723 | 1.66e-05 | 5.05e-04 | 55 |
GO:00485451 | Colorectum | SER | response to steroid hormone | 80/2897 | 339/18723 | 5.15e-05 | 1.25e-03 | 80 |
GO:00434011 | Colorectum | SER | steroid hormone mediated signaling pathway | 38/2897 | 136/18723 | 1.42e-04 | 2.82e-03 | 38 |
GO:00097551 | Colorectum | SER | hormone-mediated signaling pathway | 49/2897 | 190/18723 | 1.54e-04 | 3.00e-03 | 49 |
GO:00305221 | Colorectum | SER | intracellular receptor signaling pathway | 63/2897 | 265/18723 | 2.47e-04 | 4.20e-03 | 63 |
GO:00713832 | Colorectum | MSS | cellular response to steroid hormone stimulus | 72/3467 | 204/18723 | 8.87e-09 | 5.43e-07 | 72 |
GO:00434012 | Colorectum | MSS | steroid hormone mediated signaling pathway | 51/3467 | 136/18723 | 1.43e-07 | 6.67e-06 | 51 |
GO:00305222 | Colorectum | MSS | intracellular receptor signaling pathway | 84/3467 | 265/18723 | 1.47e-07 | 6.79e-06 | 84 |
GO:00485452 | Colorectum | MSS | response to steroid hormone | 101/3467 | 339/18723 | 2.60e-07 | 1.10e-05 | 101 |
GO:00097552 | Colorectum | MSS | hormone-mediated signaling pathway | 63/3467 | 190/18723 | 9.26e-07 | 3.23e-05 | 63 |
GO:00713833 | Colorectum | FAP | cellular response to steroid hormone stimulus | 59/2622 | 204/18723 | 2.12e-08 | 2.06e-06 | 59 |
Hugo Symbol | Variant Class | Variant Classification | dbSNP RS | HGVSc | HGVSp | HGVSp Short | SWISSPROT | BIOTYPE | SIFT | PolyPhen | Tumor Sample Barcode | Tissue | Histology | Sex | Age | Stage | Therapy Types | Drugs | Outcome |
ESRRG | SNV | Missense_Mutation | | c.964A>G | p.Ile322Val | p.I322V | P62508 | protein_coding | tolerated(0.44) | possibly_damaging(0.878) | TCGA-AP-A056-01 | Endometrium | uterine corpus endometrioid carcinoma | Female | <65 | I/II | Unknown | Unknown | SD |
ESRRG | SNV | Missense_Mutation | | c.1057N>T | p.Gly353Cys | p.G353C | P62508 | protein_coding | deleterious(0) | probably_damaging(1) | TCGA-AP-A0LM-01 | Endometrium | uterine corpus endometrioid carcinoma | Female | <65 | III/IV | Chemotherapy | cisplatin | SD |
ESRRG | SNV | Missense_Mutation | novel | c.625N>T | p.Arg209Cys | p.R209C | P62508 | protein_coding | deleterious(0) | probably_damaging(0.992) | TCGA-AP-A0LM-01 | Endometrium | uterine corpus endometrioid carcinoma | Female | <65 | III/IV | Chemotherapy | cisplatin | SD |
ESRRG | SNV | Missense_Mutation | novel | c.349C>T | p.Pro117Ser | p.P117S | P62508 | protein_coding | tolerated(0.9) | benign(0.003) | TCGA-AX-A2HC-01 | Endometrium | uterine corpus endometrioid carcinoma | Female | <65 | III/IV | Chemotherapy | paclitaxel | PD |
ESRRG | SNV | Missense_Mutation | novel | c.332N>A | p.Ser111Asn | p.S111N | P62508 | protein_coding | deleterious(0.03) | probably_damaging(0.943) | TCGA-AX-A3G9-01 | Endometrium | uterine corpus endometrioid carcinoma | Female | <65 | III/IV | Chemotherapy | carboplatin | SD |
ESRRG | SNV | Missense_Mutation | novel | c.372N>A | p.Met124Ile | p.M124I | P62508 | protein_coding | tolerated(0.05) | possibly_damaging(0.679) | TCGA-B5-A0JU-01 | Endometrium | uterine corpus endometrioid carcinoma | Female | <65 | I/II | Unknown | Unknown | SD |
ESRRG | SNV | Missense_Mutation | | c.573G>T | p.Met191Ile | p.M191I | P62508 | protein_coding | tolerated(0.16) | benign(0.015) | TCGA-B5-A0JY-01 | Endometrium | uterine corpus endometrioid carcinoma | Female | <65 | III/IV | Chemotherapy | doxorubicin | SD |
ESRRG | SNV | Missense_Mutation | rs184409476 | c.626N>A | p.Arg209His | p.R209H | P62508 | protein_coding | deleterious(0) | probably_damaging(0.989) | TCGA-B5-A11M-01 | Endometrium | uterine corpus endometrioid carcinoma | Female | <65 | I/II | Unknown | Unknown | SD |
ESRRG | SNV | Missense_Mutation | | c.1293N>T | p.Met431Ile | p.M431I | P62508 | protein_coding | deleterious(0.01) | probably_damaging(0.949) | TCGA-B5-A11N-01 | Endometrium | uterine corpus endometrioid carcinoma | Female | >=65 | I/II | Unknown | Unknown | SD |
ESRRG | SNV | Missense_Mutation | novel | c.884C>T | p.Ala295Val | p.A295V | P62508 | protein_coding | deleterious(0) | probably_damaging(0.963) | TCGA-B5-A3FC-01 | Endometrium | uterine corpus endometrioid carcinoma | Female | <65 | I/II | Unknown | Unknown | SD |
Entrez ID | Symbol | Category | Interaction Types | Drug Claim Name | Drug Name | PMIDs |
2104 | ESRRG | DRUGGABLE GENOME, NUCLEAR HORMONE RECEPTOR | | DES | DIETHYLSTILBESTROL | 12579585 |
2104 | ESRRG | DRUGGABLE GENOME, NUCLEAR HORMONE RECEPTOR | agonist | 135649823 | | |
2104 | ESRRG | DRUGGABLE GENOME, NUCLEAR HORMONE RECEPTOR | agonist | 135650300 | GENISTEIN | |
2104 | ESRRG | DRUGGABLE GENOME, NUCLEAR HORMONE RECEPTOR | agonist | 135650324 | CHEMBL193836 | |
2104 | ESRRG | DRUGGABLE GENOME, NUCLEAR HORMONE RECEPTOR | antagonist | CHEMBL10041 | AFIMOXIFENE | |
2104 | ESRRG | DRUGGABLE GENOME, NUCLEAR HORMONE RECEPTOR | agonist | 135650213 | | |
2104 | ESRRG | DRUGGABLE GENOME, NUCLEAR HORMONE RECEPTOR | agonist | 135649858 | DAIDZEIN | |
2104 | ESRRG | DRUGGABLE GENOME, NUCLEAR HORMONE RECEPTOR | | DIETHYLSTILBESTROL | DIETHYLSTILBESTROL | 12579585 |
2104 | ESRRG | DRUGGABLE GENOME, NUCLEAR HORMONE RECEPTOR | agonist | 310264689 | CHEMBL201013 | |
2104 | ESRRG | DRUGGABLE GENOME, NUCLEAR HORMONE RECEPTOR | agonist | 135649800 | AFIMOXIFENE | |